STRS Ohio’s NanoViricides NNVC Stock Holding History

STRS Ohio’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-685	Closed	-$53.8K	–	1812
2014 Q2	$58K	Buy	+685	New	+$48.6K	﹤0.01%	1608

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

STRS Ohio's NNVC Position: Q3 2014 in Review

STRS Ohio sold out of NanoViricides (NNVC) in Q3 2014, closing a stake of 685 shares — an estimated $53.8K sold.

STRS Ohio first reported a position in NNVC in Q2 2014 and held it in 1 quarter. The position peaked at $58K in Q2 2014. 53 funds tracked by Wall St. Rank hold NNVC as of Q3 2014.

STRS Ohio reported no remaining NanoViricides position as of Q3 2014 after selling out during the quarter.
STRS Ohio sold 685 NanoViricides shares in Q3 2014, an estimated $53.8K.
STRS Ohio first reported a position in NanoViricides in Q2 2014 and held it in 1 quarter.
STRS Ohio's NanoViricides position peaked at $58K in Q2 2014.
53 funds tracked by Wall St. Rank held NanoViricides as of Q3 2014.

Based on STRS Ohio's 13F filing for Q3 2014, filed 20 Oct 2014.